CH
Circulate Health, Inc.
SEC filingBiotechnology · Seattle, WA
Amount raised$13Msold at filing
Total offering$13M
Investors in the raise4count reported to the SEC
FiledJan 9, 2026first sale Jun 11, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Brad YounggrenExecutive Officer, Director, Promoter
Uri GreenwaldDirector
Robbie SchwietzerExecutive Officer
Executive officers, directors and promoters as listed on the Form D.